RE: RNS Questions4 Nov 2021 21:32
Thanks Cashburner.
It’s a pity that RNS’s intended to clarify, calm and reduce suspicions about the KRG and payment issues have sometimes had precisely the opposite effect. This part of the response you got from IR explains a great deal after some reflection:
‘The change to being paid a month later than production came as a way of sweetening the pill last April ……’
[That’s April 2020 btw]
So, looking at the payment schedule, it appears that the effect of that ‘sweetening’ was to advance October and November 2020 production payments, worth about $21.8m, into the FY 2020 cash flow, when they would ordinarily have appeared in 2021. What was not properly explained was that this was temporary and the two advanced payments would subsequently be compensated by a reduction of two in the number of payments made in 2021, as the normal payment schedule was reintroduced.
Unfortunately, the May RNS didn’t make this clear and there was no subsequent explanation. Because it was bundled in with the unrelated change to the receivables arrangement, G's stated response to the KRG's letter left the distinct impression that the KRG were acting unilaterally , unexpectedly and without G’s approval on all matters within it when, on the matter of payments, they were simply reverting to the normal schedule and spreading the remaining ten due payments for 2021 over the full year.
The resulting inconsistencies of payment dates, which were left unexplained, simply served to fuel inevitable investor concerns regarding KRG reliability.